This website uses cookies to ensure you get the best experience. Learn more about DOAJ’s privacy policy.
Hide this message
Pediatric Neurology Briefs (Nov 1988)
Affiliations
Read online
The efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma/primitive neuroectodermal tumors (MB/PNET) has been studied at the Children’s Hospital of Philadelphia, University of Pennsylvania, PA.